Content about Eli Lilly and Company

December 9, 2010
Combining Lilly and Amylin drug with insulin intake found to promote weight loss

Combining a diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals controls blood sugar and promotes weight loss more than insulin alone, according to a new study.

November 29, 2010
FDA tentatively approves Sun's generic Cymbalta

A generic drug maker announced that the Food and Drug Administration has granted tentative approval for its version of a popular antidepressant.

November 21, 2010
FDA asks Xanodyne to pull painkillers from market

A drug maker will pull a common prescription painkiller from the market following the release...

November 17, 2010
Byetta may cut cardiovascular risk for diabetes patients

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 15, 2010
Hospira launches generic Gemzar

Generic injectable drug maker Hospira has launched a version of a chemotherapy drug, the company...

November 15, 2010
JDRF, Amylin support clinical proof-of-concept study

A leading charitable funder of and advocate for Type 1 diabetes research and a drug...

November 14, 2010
Out-of-pocket costs vary widely for branded, generic drugs

The often wide gap between what consumers will pay out of pocket for a branded...

November 7, 2010
Lilly to acquire Avid

Eli Lilly's acquisition of a leader in molecular imaging development could boost its Alzheimer's disease...

November 7, 2010
Study finds GLP-1 analogues may improve blood-glucose levels, BMI

A new study conducted by University of Toronto researchers found that GLP-1 analogues not only...

November 4, 2010
FDA approves Cymbalta for treating chronic musculoskeletal pain

The Food and Drug Administration has approved a new usage for a drug used to...

November 2, 2010
Biodel receives complete response letter for Linjeta

The Food and Drug Administration has turned down an application for an insulin product made...

November 2, 2010
Lilly CEO: 'New approaches' must be found to combat diabetes

The CEO of drug maker Eli Lilly has called for a “wave of invention” to...

November 1, 2010
Elizabeth Arden to develop fragrance line for Taylor Swift

Elizabeth Arden has signed an exclusive global licensing deal with music star Taylor Swift to...

October 24, 2010
Reports: Lilly may acquire other companies following Bydureon setback

Speculation has emerged that Eli Lilly may seek to acquire several other companies in light...

October 19, 2010
FDA declines to approve Bydureon

The Food and Drug Administration declined to approve a long-anticipated diabetes drug made by Eli...

October 17, 2010
Pfizer inks deal with Biocon

Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute...

September 30, 2010
UltiMed names VP diabetes care

UltiMed, a company that makes insulin-delivery devices, has named a new executive....

September 22, 2010
FDA to allow GSK’s Avandia, with restrictions

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 19, 2010
Sanofi-Aventis: Lantus provides further blood-sugar reduction for patients with Type 2 diabetes

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

September 19, 2010
Sanofi-Aventis: Lixisenatide aids blood-glucose control for Type 2 diabetics

An investigational treatment made by French drug maker Sanofi-Aventis showed “significant” improvement in blood-glucose control...

September 16, 2010
FDA to review Actos for bladder cancer risk

The Food and Drug Administration said Friday it had begun a safety review of Takeda’s...

September 12, 2010
FDA clarifies position on low blood pressure drug

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 1, 2010
Actavis' generic Strattera gets OK from FDA

The Food and Drug Administration has approved a generic drug made by Actavis for treating...

August 31, 2010
FDA approves Sun's generic Strattera

A generic drug maker has received regulatory approval for its version of an attention deficit...

August 31, 2010
Lilly's Evista patents upheld in appeals court ruling

Eli Lilly's method-of-use patents for its osteoporosis drug were declared valid by a federal court...

© 2013 Drug Store News. All Rights Reserved.